{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:49:09Z","timestamp":1760143749165,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:00:00Z","timestamp":1606521600000},"content-version":"am","delay-in-days":424,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.lpm.2019.09.018","type":"journal-article","created":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T09:56:18Z","timestamp":1572688578000},"page":"1037-1042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quel b\u00e9n\u00e9fice de l\u2019angioplastie coronaire programm\u00e9e pour le traitement de la maladie coronaire stable\u00a0?"],"prefix":"10.1016","volume":"48","author":[{"given":"Pierre Vladimir","family":"Ennezat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Christine","family":"Malergue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Czitrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvestre","family":"Mar\u00e9chaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Tricot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry H.","family":"Le Jemtel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Vincentelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2019.09.018_bib0075","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.300.15.1765","article-title":"Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention","volume":"300","author":"Lin","year":"2008","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.lpm.2019.09.018_bib0080","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002594","article-title":"Practice-level variation in outpatient cardiac care and association with outcomes","volume":"5","author":"Clough","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.lpm.2019.09.018_bib0085","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1161\/CIRCULATIONAHA.118.036904","article-title":"Planning and conducting the ISCHEMIA trial","volume":"138","author":"Maron","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2019.09.018_bib0090","doi-asserted-by":"crossref","unstructured":"Pitt B, Waters D, Brown WV et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus revascularization treatment investigators. N Engl J Med. 341:70\u201376.","DOI":"10.1056\/NEJM199907083410202"},{"key":"10.1016\/j.lpm.2019.09.018_bib0095","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(97)07298-X","article-title":"RITA-2\u00a0trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2019.09.018_bib0100","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2019.09.018_bib0105","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1161\/01.CIR.0000072790.23090.41","article-title":"Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography","volume":"107","author":"Hachamovitch","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2019.09.018_bib0110","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2\u00a0diabetes and coronary artery disease","volume":"360","author":"BARI 2D Study Group","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2019.09.018_bib0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2019.09.018_bib0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomized controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2019.09.018_bib0125","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jamainternmed.2013.12855","article-title":"Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials","volume":"174","author":"Stergiopoulos","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.lpm.2019.09.018_bib0130","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.amjcard.2009.07.043","article-title":"COURAGE Study Investigators. Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease","volume":"104","author":"Sedlis","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.lpm.2019.09.018_bib0135","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1056\/NEJMoa041905","article-title":"Coronary-artery revascularization before elective major vascular surgery","volume":"351","author":"McFalls","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2019.09.018_bib0070","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1161\/CIRCULATIONAHA.105.560433","article-title":"Temporal trends in the utilization of diagnostic testing and treatments for cardiovascular disease in the United States, 1993\u20132001","volume":"113","author":"Lucas","year":"2006","journal-title":"Circulation"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075549821930404X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075549821930404X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:05:27Z","timestamp":1760105127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075549821930404X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S075549821930404X"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2019.09.018","relation":{},"ISSN":["0755-4982"],"issn-type":[{"type":"print","value":"0755-4982"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quel b\u00e9n\u00e9fice de l\u2019angioplastie coronaire programm\u00e9e pour le traitement de la maladie coronaire stable\u00a0?","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2019.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}